Healthcare provider profile · identity verified

Jill E. Nye, D.O.

Family Practice · KULPMONT, PA · NPI 1427011337

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1051	279
Levothyroxine Sodium	Levothyroxine Sodium	613	142
Lisinopril	Lisinopril	589	168
Omeprazole	Omeprazole	429	126
Losartan Potassium	Losartan Potassium	382	112
Amlodipine Besylate	Amlodipine Besylate	363	98
Furosemide	Furosemide	335	70
Metformin Hcl	Metformin Hcl	330	72
Simvastatin	Simvastatin	325	73
Rosuvastatin Calcium	Rosuvastatin Calcium	256	69
Metoprolol Tartrate	Metoprolol Tartrate	214	53
Escitalopram Oxalate	Escitalopram Oxalate	212	44
Hydrochlorothiazide	Hydrochlorothiazide	203	60
Metoprolol Succinate	Metoprolol Succinate	203	60
Alendronate Sodium	Alendronate Sodium	190	51
Ozempic	Semaglutide	181	39
Tramadol Hcl	Tramadol Hcl	178	39
Gabapentin	Gabapentin	150	47
Fluticasone Propionate	Fluticasone Propionate	147	53
Jardiance	Empagliflozin	143	29
Atenolol	Atenolol	141	29
Montelukast Sodium	Montelukast Sodium	140	39
Duloxetine Hcl	Duloxetine Hcl	137	36
Clopidogrel	Clopidogrel Bisulfate	125	25
Pantoprazole Sodium	Pantoprazole Sodium	124	36
Albuterol Sulfate Hfa	Albuterol Sulfate	121	45
Lorazepam	Lorazepam	121	30
Famotidine	Famotidine	120	37
Potassium Chloride	Potassium Chloride	112	33
Eliquis	Apixaban	108	23
Warfarin Sodium	Warfarin Sodium	105	26
Metformin Hcl Er	Metformin Hcl	104	34
Mirtazapine	Mirtazapine	95	11
Ezetimibe	Ezetimibe	90	26
Pregabalin	Pregabalin	90	21
Sertraline Hcl	Sertraline Hcl	88	26
Esomeprazole Magnesium	Esomeprazole Magnesium	85	13
Allopurinol	Allopurinol	83	22
Carvedilol	Carvedilol	81	25
Trazodone Hcl	Trazodone Hcl	80	20
Trulicity	Dulaglutide	79	15
Fluoxetine Hcl	Fluoxetine Hcl	77	19
Citalopram Hbr	Citalopram Hydrobromide	73	22
Oxybutynin Chloride	Oxybutynin Chloride	68	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	18
Tamsulosin Hcl	Tamsulosin Hcl	67	23
Divalproex Sodium	Divalproex Sodium	65	suppressed
Digoxin	Digoxin	61	suppressed
Glipizide Er	Glipizide	61	16
Buspirone Hcl	Buspirone Hcl	60	21
Donepezil Hcl	Donepezil Hcl	60	22
Alprazolam	Alprazolam	59	15
Meloxicam	Meloxicam	57	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	16
Hydroxyzine Hcl	Hydroxyzine Hcl	54	14
Diltiazem Hcl	Diltiazem Hcl	52	suppressed
Bupropion Xl	Bupropion Hcl	47	15
Prednisone	Prednisone	46	38
Torsemide	Torsemide	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	43	38
Verapamil Er	Verapamil Hcl	43	14
Clonazepam	Clonazepam	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	17
Nystatin	Nystatin	38	17
Ondansetron Hcl	Ondansetron Hcl	37	16
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Baclofen	Baclofen	35	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Novolog Flexpen	Insulin Aspart	33	suppressed
Topiramate	Topiramate	33	12
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	17
Clonidine Hcl	Clonidine Hcl	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	12
Primidone	Primidone	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	19
Valsartan	Valsartan	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Cephalexin	Cephalexin	25	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Ibuprofen	Ibuprofen	25	11
Lovastatin	Lovastatin	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Synthroid	Levothyroxine Sodium	25	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Repaglinide	Repaglinide	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	11
Finasteride	Finasteride	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Nitroglycerin	Nitroglycerin	23	18
Chlorthalidone	Chlorthalidone	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Valacyclovir	Valacyclovir Hcl	21	11
Aripiprazole	Aripiprazole	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Estradiol	Estradiol	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	13
Metolazone	Metolazone	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	15
Fluconazole	Fluconazole	15	13
Glimepiride	Glimepiride	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Unifine Pentips	Pen Needle, Diabetic	15	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	14	14
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	14	14
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Levoxyl	Levothyroxine Sodium	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Temazepam	Temazepam	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Xiidra	Lifitegrast	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Brinzolamide	Brinzolamide	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Ramipril	Ramipril	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error